Established in UK in 1925, Croda Pharma is committed to empowering biologics delivery. We’re ingredients supplier and partner of world-renowned pharmaceutical companies, universities and research institutions, offering a portfolio of high-purity pharmaceutical excipients, world leading vaccine adjuvants, innovative lipids, which are widely used in four technology platforms: small molecule delivery, protein delivery, nucleic acid delivery and vaccine adjuvant systems. ·Super Refined™ polysorbate series, the high-purity excipients, used in many blockbuster single antigen R&D products around the world, with a market share of more than 90% in the North American biopharmaceutical market.

• More than 80 years of experience in vaccine adjuvant research and commercialization, a full range of vaccine adjuvant solutions.
• In 2022, we’re awarded as the world's best vaccine supplier.
• Avanti has 50+ years of experience in innovative lipid research and commercialization, providing 2000+ innovative lipid excipients for research, lipid customization and CMO contract manufacturing services.
• Provided 4 LNP key lipid excipients for Pfizer's first global COVID-19 mRNA vaccine.

We are not only an ingredient supplier, but also can provide comprehensive technical support and comprehensive regulatory services to help customers accelerate the drug development process, shorten the time to market, jointly respond to disease challenges, and enable efficient drug delivery.

More information, follow our Wechat account:Croda禾大醫(yī)藥健康 And Welcome to Croda China website to discover our advantages. www.crodapharma.com